ipatasertib   Click here for help

GtoPdb Ligand ID: 7887

Synonyms: GDC-0068
PDB Ligand
Compound class: Synthetic organic
Comment: Ipatasertib is an inhibitor of the AKT family of protein kinases [1]. The synthesis of ipatasertib is described in patent WO2008006040 [2] and [1] where it is compound 28 (the Supporting Information for this article contains activity data for compound 28 against a full kinase screening panel). This compound is also represented on PubChem by CID 23649210.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 7
Topological polar surface area 81.59
Molecular weight 457.22
XLogP 2.75
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES CC(NCC(C(=O)N1CCN(CC1)c1ncnc2c1C(C)CC2O)c1ccc(cc1)Cl)C
Isomeric SMILES CC(NC[C@@H](C(=O)N1CCN(CC1)c1ncnc2c1[C@H](C)C[C@H]2O)c1ccc(cc1)Cl)C
InChI InChI=1S/C24H32ClN5O2/c1-15(2)26-13-19(17-4-6-18(25)7-5-17)24(32)30-10-8-29(9-11-30)23-21-16(3)12-20(31)22(21)27-14-28-23/h4-7,14-16,19-20,26,31H,8-13H2,1-3H3/t16-,19-,20-/m1/s1
1. Blake JF, Xu R, Bencsik JR, Xiao D, Kallan NC, Schlachter S, Mitchell IS, Spencer KL, Banka AL, Wallace EM et al.. (2012)
Discovery and preclinical pharmacology of a selective ATP-competitive Akt inhibitor (GDC-0068) for the treatment of human tumors.
J Med Chem, 55 (18): 8110-27. [PMID:22934575]
2. Mitchell IS, Blake JF, Xu R, Kallan NC, Xiao D, Spencer KL, Bencsik JR, Liang J, Safina B, Zhang B et al.. (2010)
Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors.
Patent number: WO2008006040. Assignee: Array Biopharma Inc and Genentech Inc. Priority date: 06/06/2006. Publication date: 10/01/2010.